Thursday, May 3, 2018

Autophagy-focused Casma Therapeutics debuts with $58.5 million from Third Rock

The biotech will first tackle lysosomal storage disorders

via Chemical & Engineering News: Biological SCENE https://ift.tt/2FDoUhR
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)